Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

BackgroundPrior Studies have suggested better outcomes in smokers compared with nonsmokers receiving clopidogrel (“smoker's paradox”). The impact of a more intensive clopidogrel regimen on ischemic and bleeding risks in smokers with acute coronary syndromes requiring percutaneous coronary inter...

Full description

Bibliographic Details

Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Matthias Bossard, Christopher B. Granger, Jean‐Francois Tanguay, Gilles Montalescot, David P. Faxon, Sanjit S. Jolly, Petr Widimsky, Kari Niemela, Philippe Gabriel Steg, Madhu K. Natarajan, Peggy Gao, Keith A. A. Fox, Salim Yusuf, Shamir R. Mehta
Format:	Article
Language:	English
Published:	Wiley 2017-11-01
Subjects:	acute coronary syndrome antiplatelet antiplatelet therapy percutaneous coronary intervention smoking stent
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.117.006577